TGF-beta Imprinted Natural Killer Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TGF-beta Imprinted Natural Killer Cells, covering 2026-02-13 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma [EARLY_Phase 1]